THERAVANCE INC (THRX)
(Delayed Data from NSDQ)
$9.81 USD
+0.04 (0.41%)
Updated Jan 8, 2016 03:59 PM ET
NA Value
NA Growth NA Momentum NA VGMEarnings News For THRX
-
Theseus Pharmaceuticals Announces Business Highlights and Reports Second Quarter 2023 Financial Results
-
Theseus Pharmaceuticals Announces Business Highlights and Reports First Quarter 2023 Financial Results
-
Theseus Pharmaceuticals Announces Business Highlights and Reports Fourth Quarter and Full Year 2022 Financial Results
-
Theseus Pharmaceuticals Announces Business and Pipeline Highlights and Reports Third Quarter 2022 Financial Results
-
Theseus Pharmaceuticals Announces Business and Pipeline Highlights and Reports Third Quarter 2022 Financial Results
-
Theseus Pharmaceuticals Announces Business and Pipeline Highlights and Reports Third Quarter 2022 Financial Results
-
Theseus Pharmaceuticals Announces Business and Pipeline Highlights and Reports Third Quarter 2022 Financial Results
-
Theravance (THRX) Reports Wider-than-Expected Q1 Loss
-
Theravance (THRX) Falls on Wider-than-Expected Loss in Q3
-
Theravance (THRX) Incurs Narrower-than-Expected Loss in Q2